Gonadotropin-releasing hormone agonist (GnRH-a) therapy alters activity of plasminogen activators, matrix metalloproteinases, and their inhibitors in rat models for adhesion formation and endometriosis: potential GnRH-a-regulated mechanisms reducing adhesion formation

Kathy L. Sharpe-Timms, Sharpe-Timms KL, K L Sharpe-Timms, Zimmer RL, Randall L. Zimmer, R L Zimmer, Wendy J. Jolliff, Jolliff WJ, W J Jolliff, Wright JA, Jean Ann Wright, J A Wright, Warren B. Nothnick, Nothnick WB, W B Nothnick, Thomas E. Curry, T E Curry, Curry TE
Fertility and sterility · 1998 · vol. 69(5) , pp. 916–923 · doi:10.1016/s0015-0282(98)00032-6 · PMID:9591503 · W1837228878
Other OA: closed CC0 ⤵ 38 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-09 ⓘ

Gonadotropin-releasing hormone agonist therapy in rats reduced adhesion formation by decreasing peritoneal fluid plasminogen activator and matrix metalloproteinase activities while increasing inhibitor activities.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To evaluate the effects of a gonadotropin-releasing hormone agonist (GnRH-a) on plasminogen activator (PA), matrix metalloproteinase (MMP), plasminogen activator inhibitor (PAI) and matrix metalloproteinase inhibitor (MMPI) activities in peritoneal fluid relative to GnRH-a-induced reduction of adhesion formation. DESIGN: Continuation of prospective randomized study using surgical models for adhesion formation. SETTING: Department of Obstetrics and Gynecology research laboratory at the University of Missouri School of Medicine. PATIENT(S): Forty reproductively cycling female Sprague-Dawley rats. INTERVENTION(S): Female rats were injected with depot GnRH-a or diluent and randomly assigned to adhesion and endometriosis surgeries. Peritoneal fluid was collected prior to (time 1) and 7 weeks from (time 2) initial surgery. MAIN OUTCOME MEASURE(S): Peritoneal fluid was analyzed for PA, PAI, MMP, and MMPI activities. RESULT(S): At time 1, MMP and MMPI activities were similar in all rats; however, PA and PAI activities were less in rats pretreated with GnRH-a than with diluent. Between time 1 and time 2, GnRH-a-treated rats showed an increase in PAI and MMPI activities without significant changes in PA or MMP activities, whereas rats receiving diluent showed a significant increase in PAI and MMP activities but no significant changes in PA or MMPI activities. At time 2, rats receiving GnRH-a had less PA and MMP activities than those receiving diluent. Adhesion scores showed a positive correlation with MMP activity. CONCLUSION(S): In the absence of GnRH-a therapy, surgical tissue manipulation increased peritoneal fluid MMP and PAI activity. Gonadotropin-releasing hormone agonist therapy decreased PA and MMP activities and also increased PAI and MMPI activities. This GnRH-a-induced shift to a less invasive phenotype may alter fibrinolysis and extracellular matrix remodeling and thereby play a role in the mechanism of GnRH-a-induced reduction in adhesion formation.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Leuprolide Metalloendopeptidases Plasminogen Activators Plasminogen Inactivators Tissue Adhesions Animals Animals Disease Models, Animal Disease Models, Animal Endometriosis Endometriosis Female Female Leuprolide Leuprolide Metalloendopeptidases Metalloendopeptidases Metalloendopeptidases Plasminogen Activators

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (41)

Cited by (39)

Source provenance

europepmc
last seen: 2026-10-18T09:30:06.152893+00:00
openalex
last seen: 2026-05-11T05:58:56.137231+00:00
pubmed
last seen: 2026-10-08T22:00:35.617750+00:00
unpaywall
last seen: 2026-08-14T06:25:32.811723+00:00
License: CC0 · commercial use OK